Background: Mild cognitive impairment (MCI) is considered to be the borderline of cognitive
changes associated with aging and very early dementia. Cognitive functions in MCI can …

Alzheimer's disease (AD) causes a rapid deterioration in cognitive and physical functions,
including problem-solving, memory, language, and daily activities. Mild cognitive impairment …

Objective The study objective is to evaluate the use of qEEG data for the cross‐sectional
differentiation of mild cognitive impairment (MCI) from mild Alzheimer's disease (AD) and in …

This article reports the biomarkers of the Mild Cognitive Impairment (MCI) among the elderly
group aged around 60-75 years old by analyzing the EEG signals recorded by using the …

Currently established and employed biomarkers of Alzheimer's disease (AD) predominantly
mirror AD-associated molecular and structural brain changes. While they are necessary for …

Alzheimer's disease (AD) pathological changes may begin up to decades earlier than the
appearance of the first symptoms of cognitive decline. Subjective cognitive decline (SCD) …

Electroencephalography (EEG) is an easily accessible and low-cost modality that might
prove to be aparticularly powerful tool for the identification of subtle functional changes …

Background: Mild cognitive impairment (MCI) is associated with clinical progression to
Alzheimer's disease (AD) but not all patients with MCI convert to AD. However, it is important …

BACKGROUND: Successful early detection of mild cognitive impairment (MCI) and
Alzheimer's disease demands the identification of biomarkers capable of distinguishing …

Background: Mild (MCI) and Subjective Cognitive Impairment (SCI) are conditions at risk of
developing Alzheimer's disease (AD). Differential between normal aging at early stages can …